Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.

Shu-Ying Liu,Xiao-Lin Yu,Jie Zhu,Xiang-Meng Liu,Yue Zhang,Quan-Xiu Dong,Shan Ma,Rui-Tian Liu

DOI: https://doi.org/10.1016/j.brainres.2018.06.009

IF: 3.61

2018-01-01

Brain Research

Abstract:•IVIg significantly attenuated motor and cognitive deficits in R6/2 mice.•IVIg decreased mutant huntingtin protein levels in the brains of R6/2 mice.•IVIg ameliorated neuroinflammation and oxidative stress in R6/2 mice.•IVIg inhibited NF-κB activation in the brains of R6/2 mice.